Absci Corporation (ABSI) vs Palvella Therapeutics, Inc. (PVLA)
A side-by-side comparison of Absci Corporation and Palvella Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABSI
Absci Corporation
$10.54HealthcareDelayed quote: Oct 6, 2026, 12:35 PM EDT
PVLA
Palvella Therapeutics, Inc.
$129.53HealthcareDelayed quote: Oct 6, 2026, 12:30 PM EDT
Total return — ABSI vs PVLA
growth of $100 · dividends reinvested · last 2yABSI +186.8% (+69.4%/yr)PVLA +677.4% (+178.8%/yr)PVLA compounded faster over this window
ABSI PVLA
ABSI vs PVLA: by the numbers
- •PVLA is the larger company ($1.86B vs $1.79B market cap).
- •Both run net losses; PVLA's is the smaller (0.00% vs -7756.37% net margin).
Metrics side by side
Valuation
| Metric | ABSI | PVLA |
|---|---|---|
| P/S ratio | 1143.80 | N/A |
| P/B ratio | 7.25 | 8.57 |
Profitability
| Metric | ABSI | PVLA |
|---|---|---|
| Gross margin | -319.36% | 0.00% |
| Operating margin | -4454.21% | 0.00% |
| Net margin | -7756.37% | 0.00% |
| ROE | -49.19% | -28.45% |
| ROIC | -52.66% | -23.90% |
Growth (annualized)
| Metric | ABSI | PVLA |
|---|---|---|
| Revenue CAGR (5Y) | -22.08% | N/A |
| Total return CAGR (5Y) | 0.89% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.